Product image of Klozapol (Clozapine) supplied by GNH India

Klozapol

Active Ingredient:
Clozapine
Origin:
EU

Klozapol (Clozapine)

Clozapine, the active ingredient in Klozapol, is an atypical antipsychotic presented as an oral tablet for oral use. It is indicated for schizophrenia, treatment‑resistant schizophrenia, and for reducing suicidal behavior in patients with schizophrenia. The medication is administered orally and requires careful clinical monitoring due to its pharmacological profile.

GNH India supplies Klozapol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality assurance and regulatory compliance across markets. The product is distributed under strict temperature‑controlled conditions to maintain stability.

Manufacturer / TM Owner

Egis Pharmaceuticals Plc

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Clozapine is used in the management of psychotic disorders, primarily schizophrenia.
  • Schizophrenia: alleviates positive and negative symptoms in patients with schizophrenia.
  • Treatment‑resistant schizophrenia: provides symptom control when other antipsychotics have failed.
  • Suicidal behavior in schizophrenia: reduces the risk of suicide in affected individuals.

How It Works

  • Clozapine acts as an antagonist at dopamine D2 receptors and serotonin 5‑HT2A receptors, while also modulating activity at several other neurotransmitter sites such as dopamine D1, D4, α‑adrenergic, histamine H1, and muscarinic receptors. This broad receptor profile reduces dopaminergic over‑activity linked to psychosis and balances serotonergic pathways, contributing to its efficacy in treatment‑resistant schizophrenia and in lowering suicidal risk.

Side Effects

Clozapine may cause a range of adverse reactions, varying from mild to potentially life‑threatening.

Common Side Effects

  • Sedation: drowsiness or feeling unusually sleepy.
  • Weight gain: increase in body weight over time.
  • Constipation: reduced bowel movements.
  • Hypersalivation: excessive saliva production.

Serious or Rare Side Effects

  • Agranulocytosis: severe drop in white blood cells requiring regular monitoring.
  • Myocarditis: inflammation of the heart muscle.
  • Seizures: risk of convulsive episodes, especially at higher doses.
  • Neuroleptic malignant syndrome: rare but life‑threatening reaction with fever and muscle rigidity.

Precautions & Warnings

When prescribing clozapine, clinicians should observe several safety measures to minimize risks.

  • Blood monitoring: perform regular complete blood counts to detect agranulocytosis early.
  • Cardiovascular assessment: monitor heart rate and blood pressure for signs of myocarditis or arrhythmia.
  • Metabolic monitoring: check weight, glucose, and lipid levels periodically.
  • Pregnancy considerations: use only if benefits outweigh potential risks (Category C).
  • Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Avoid Interactions

Clozapine interacts with several medicines, requiring dose adjustments or avoidance.

Major Interactions (Avoid)

  • Myelosuppressive agents: concurrent use may exacerbate bone‑marrow suppression.
  • Strong CYP1A2 inhibitors (e.g., fluvoxamine): can markedly increase clozapine plasma levels.
  • Drugs causing severe constipation (e.g., anticholinergics): may heighten gastrointestinal adverse effects.

Moderate Interactions (Monitor Closely)

  • Smoking cessation: nicotine withdrawal can raise clozapine concentrations.
  • CYP1A2 inducers (e.g., carbamazepine): may lower clozapine levels, reducing efficacy.
  • CNS depressants (e.g., benzodiazepines): can enhance sedation and respiratory depression.

Frequently Asked Questions

Klozapol contains the active ingredient clozapine and is prescribed for the treatment of schizophrenia, including cases that have not responded to other antipsychotic medications, as well as for reducing the risk of suicidal behavior in patients with schizophrenia.

Clozapine works by blocking dopamine D2 receptors and serotonin 5‑HT2A receptors while also influencing several other neurotransmitter systems. This broad receptor activity helps to balance dopaminergic and serotonergic pathways, which reduces psychotic symptoms and lowers suicidal risk in susceptible patients.

The dose of Klozapol is individualized. A qualified prescriber determines the starting dose, titration schedule, and maintenance dose based on the patient’s clinical response, tolerability, and laboratory monitoring. No fixed regimen is provided here.

Clozapine is classified as Pregnancy Category C, meaning risk cannot be ruled out. It should only be used if the potential benefit justifies the potential risk to the fetus. Use during breastfeeding is generally not recommended because the drug is excreted in milk.

To order Klozapol, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with many second‑generation antipsychotics, clozapine shows superior efficacy in treatment‑resistant schizophrenia but requires more intensive monitoring for blood dyscrasias and cardiac effects. Other agents may have a more favorable safety profile but are often less effective in refractory cases.

Store Klozapol at ambient temperature, preferably below 25 °C. Keep the tablets in their original container, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Klozapol is taken orally as a tablet. The tablet should be swallowed whole with a glass of water, usually once or twice daily as directed by the prescribing clinician. Dosing times may be adjusted based on tolerability and therapeutic response.

The most serious risks include agranulocytosis (a potentially fatal drop in white blood cells), myocarditis (inflammation of the heart muscle), seizures, and neuroleptic malignant syndrome. Regular blood monitoring and clinical assessment are essential to detect these complications early.

Klozapol should be avoided in patients with known hypersensitivity to clozapine, uncontrolled epilepsy, severe cardiac disease, existing bone‑marrow disorders, or a history of agranulocytosis. It is also contraindicated in individuals taking certain myelosuppressive drugs without close supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Clozapine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT